Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01SVO
|
|||
| Drug Name |
EIDD-1931
|
|||
| Synonyms |
N-hydroxycytidine; NHC; NSC-529856; CTK0I1923; DTXSID70326527; NSC529856; SCHEMBL6674536
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Investigative | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H13N3O6
|
|||
| Canonical SMILES |
C1=CN(C(=O)N=C1NO)C2C(C(C(O2)CO)O)O
|
|||
| InChI |
1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1
|
|||
| InChIKey |
XCUAIINAJCDIPM-XVFCMESISA-N
|
|||
| CAS Number |
CAS 3258-02-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | An Orally Bioavailable Broad-Spectrum Antiviral Inhibits SARS-CoV-2 in Human Airway Epithelial Cell Cultures and Multiple Coronaviruses in Mice. Sci Transl Med. 2020 Apr 6;eabb5883. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.